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Background: Symptoms in the elderly patients with severe aortic stenosis (AS) and co-morbidities seem to lack in
specificity. Therefore, objective parameters for increased left ventricular(LV) filling pressures are needed. The aim of
this study was to investigate the correlation between the septal, lateral and average E/e’ ratio and the value of the
N-terminal pro-hormone of brain natriuretic peptide (NT-proBNP).
Methods: Two-hundred-fifty consecutive symptomatic patients (mean age 80 ± 8 years, 52 % men) with severe
AS underwent transthoracic echocardiography and NT-proBNP measurement.
Results: In the overall population the septal E/e’ (r = 0,459, r2 = 0,21, P <0,0001), lateral E/e’ (r = 0,322, r2 = 0,10,
P <0,0001), and the average E/e’ (r = 0,432, r2 = 0,18, P <0,0001) were all significantly correlated to NT-proBNP. After
the exclusion of patients with confounders (more than mild aortic or mitral regurgitation, severe renal dysfunction,
obesity or severe COPD) the septal E/e’ (r = 0,584, r2 = 0,34, P <0,0001), lateral E/e’ (r = 0,377, r2 = 0,14, P <0,0001),
and the average E/e’ (r = 0,487, r2 = 0,24, P <0,0001) were all significantly better correlated to NT-proBNP. In obese
patients no significant correlations were seen. Previous bypass surgery did not alter the correlations.
Conclusions: In elderly patients with severe symptomatic AS there is a significant correlation between the E/e’ ratio
and NT-proBNP, in particular after exclusion of confounders. The correlation was best for the septal E/e’ ratio and
was preserved in patients with a history of bypass surgery.
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Aortic stenosis (AS) is the most common valvular heart
disease in the Western world and its prevalence is
expected to increase due to the aging of the population
[1]. Current recommendations warrant the presence of
symptoms in order to indicate aortic valve replacement
[2]. However, in elderly patients symptoms related to
increased left ventricular (LV) filling pressures are less
specific, because of the normal aging process and the
multiple comorbidities [3]. One objective parameter of
increased LV filling pressures is the echocardiographic
ratio of the transmitral E-wave velocity and early* Correspondence: m.strachinaru@erasmusmc.nl
1Department of Cardiology, Thorax Center, Erasmus MC Rotterdam, PB 412,
3000 CA, Rotterdam, The Netherlands
Full list of author information is available at the end of the article
© 2015 Strachinaru et al. This is an Open Acce
License (http://creativecommons.org/licenses/
any medium, provided the original work is pr
(http://creativecommons.org/publicdomain/zediastolic velocity of the myocardium, the so called E/e’
ratio [4–7]. Although the value of this ratio may be less
reliable in elderly AS patients with important annular
calcifications [7], the E/e’ was proven to be a strong
predictor of mortality in non-operated elderly patients
with AS, especially in conjunction with the N-terminal
pro-hormone of brain natriuretic peptide (NT-proBNP)
[8]. This hormone reflects the total burden of the disease
on the LV, and has been demonstrated to have a good
prognostic value in the setting of severe AS [9–16].
This study sought to assess the relation between the
E/e’ ratio and NT-proBNP. More specifically, the values
of the septal versus lateral myocardial wall derived E/e’
ratio were investigated in detail.ss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Patient population
After exclusion of patients with an aortic or mitral valvular
prosthesis, mitral stenosis or significant areas of focal LV
akinesia (defined as an akinetic region extending to at least
3 segments, involving the basal septum and/or the basal lat-
eral wall) the study included 250 consecutive subjects
(mean age 80 ± 8 years, 52 % men) with symptomatic severe
AS, defined as an aortic valve area less than 1 cm2 and/or
less than 0.6 cm2/m2 and available NT-proBNP level who
were treated by transcatheter aortic valve replacement
(TAVI). The study was approved by the Medical Ethical
Committee of the Erasmus MC. All patients gave their
informed consent.
Transthoracic echocardiography
Two-dimensional echocardiography was performed using
a Philips iE33 system (Philips, Best, The Netherlands)
with the patient in the left lateral decubitus position.
Echocardiographic studies were performed by an inde-
pendent experienced echocardiographer, blinded to the
patient’s clinical and biochemical status. All echocardio-
grams were saved as video loops or still frames in a digital
database and were reanalyzed by an experienced cardiolo-
gist (MS). The LV ejection fraction cut-off value of 50 %
was calculated using the biplane modified Simpson rule.
The mitral inflow velocity profile (E/A wave ratio, E wave
deceleration time) was assessed with pulse-wave Doppler.
The early diastolic velocities at the septal and lateral
annulus level were assessed with pulse-wave Tissue
Doppler from a standard apical 4-chamber view.
Blood sampling
Venous blood samples were drawn from patients with
AS within 30 min of the Doppler echocardiography study
from an antecubital vein into EDTA acid Vacutainer test
tubes (Mediost BV, Doesburg, The Netherlands) after
30 min of supine rest. Samples were placed immediately
on ice, and plasma separation was performed at 4 °C. For
NT-proBNP determination, an electrochemiluminescence
immunoassay (ProBNP Elecsys, Roche Diagnostics GmbH,
Mannheim, Germany) was used. For the evaluation of
renal function, serum creatinine levels were determined
and glomerular filtration rate (GFR) was calculated using
the 2009 CKD-EPI creatinine equation [17].
Definitions of possible confounders
Impaired ejection fraction was defined as <50 %. Obesity was
defined as a BMI (body mass index) above 30 kg/m [2, 18].
Severe COPD was considered in GOLD class III or IV [19].
Severe impairment of the renal function was defined
as GFR less than 30 ml/min/1,73 m2, present for more
than 3 months, as estimated by 2009 CKD-EPI creatinine
equation [17]. Aortic and mitral regurgitation were assessedsemi quantitatively according to current guidelines for the
evaluation of native valves [20].
Significant coronary artery disease was defined as >50 %
stenosis in at least one coronary artery.
Pulmonary hypertension was considered when the
estimated pulmonary pressure derived from Doppler trac-
ings of the tricuspid insufficiency was above 40 mmHg.
Statistical analysis
Continuous variables are presented as means (± SD) if
normally distributed, or otherwise by geometric means
for natriuretic peptide levels. Because of the very large
range of values of the natriuretic peptide and the abnormal
distribution of this variable, the log10 of the NT proBNP
was used in the analysis. Categorical variables are presented
as frequencies and percentages. Differences between similar
continuous variables were assessed by the paired-samples
t test. Multivariable linear regression was performed in
order to identify the possible confounders. Correlations
were computed using Pearson’s method, and graphically
represented with linear regression lines whenever appro-
priate. For nonlinear parameters, a best-fit regression line
was traced, using multiple nonlinear regression equations
and choosing the most statistically significant model that
fitted the data. A two-sided p value less than 0.05 was used
for declaring statistical significance. All statistical analyses
were performed with SPSS 21.0 software (SPSS Inc,
Chicago, IL, USA).
Results
The baseline characteristics of the population are shown in
Table 1. All patients were symptomatic. 66 patients (26 %)
had angina and only 18(7 %) syncope. 149(60 %) were in
class NYHA III and IV, 76 (30 %) in class II and 17(7 %) in
NYHA class I. In 8 patients NYHA class could not be
determined. Impaired LV function was present in 60
patients (24 %). Other potential confounders were present
in 139 patients (56 %):, severe COPD in 17 (7 %), obesity
in 52 (21 %), severe renal dysfunction in 27 (11 %) and
significant associated mitral or aortic regurgitation or a
combination of the two in 61 (24 %). In Table 2 the mean
values for the echocardiographic parameters and
NT-proBNP data are shown. The E/A ratio was 1.0 ± 0.6,
E-wave deceleration time was 240 ± 86 ms, septal E/e’ was
20.2 ± 9.1, lateral E/e’ was 15.7 ± 7.2, and average E/e’ was
17.4 ± 6.9. NT-proBNP was 271 pmol/L (95 % confidence
interval 161,226), Log10 NT-proBNP was 2.3 ± 0.6.
Correlations between the diastolic parameters and
NT-proBNP
As seen in Fig. 1, in the overall population the septal
E/e’ (r = 0,459, r2 = 0,21, P <0,0001), lateral E/e’ (r = 0,322,
r2 = 0,10, P <0,0001), and the average E/e’ (r = 0,432,
r2 = 0,18, P <0,0001) were all significantly correlated to
Table 2 Echocardiographic and biological data
Maximal pressure gradient (mmHg) 73 ± 23
Mean pressure gradient (mmHg) 44 ± 15
Pulmonary artery pressure (mmHg) 39 ± 13
Ejection fraction (%) 55 ± 12
E/A ratio 1,0 ± 0,6
e’ septal (cm/s) 4,6 ± 1,7
e’ lateral (cm/s) 6,3 ± 2,4
e’ average (cm/s) 5,5 ± 1,9
E/e’ septal 20,2 ± 9,1
E/e’ lateral 15,7 ± 7,2
E/e’ average 17,4 ± 6,9
E-wave deceleration time (ms) 240 ± 86
N terminal pro Brain Natriuretic Peptide (pmol/l) 217, 95 % CI (161,226)
Log10 N-terminal pro Brain Natriuretic Peptide 2,3(±0,6)
Data are presented as mean ± SD or number (percentage %) for normally
distributed values and as geometric mean and 95 % CI for NT-proBNP
Table 1 Baseline characteristics of the study patients
Variable Study population
n = 250
Age 80(±8)
Male gender 129(52 %)
BMI > 30 kg/m2 52(21 %)
Diabetes 69(28 %)
Severe renal dysfunction 27(11 %)
Atrial fibrillation 47(19 %)
Coronary artery disease 138(55 %)
Previous CABG 53(21 %)
PCI 90(36 %)
COPD GOLD 3-4 17(7 %)
NYHA class I 17(7 %)
NYHA class II 76(30 %)
NYHA class III-IV 149(60 %)
Angor 66(26 %)
Syncope 18(7 %)
Pulmonary hypertension 85(34 %)
Ejection fraction less than 50 % 60(24 %)
More than mild mitral regurgitation 39(16 %)
More than mild aortic regurgitation 29(12 %)
Data are presented as mean ± SD or number (percentage %)
BMI = body mass index; CABG = coronary artery by-pass graft surgery;
COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative
for Chronic Obstructive Lung Disease classification of COPD; NYHA
class = New York Heart Association classification of heart failure symptoms;
PCI = percutaneous coronary intervention
Strachinaru et al. Cardiovascular Ultrasound  (2015) 13:29 Page 3 of 7NT-proBNP. Also, the E/A ratio (r = 0,230, r2,= 0,05,
P <0,001), and E-wave decelaration time (r = −0,263,
r2 = 0,07, P <0,0001) were significantly correlated to
NT-proBNP.
Influence of ejection fraction on the correlations between
the E/e’ ratio and NT-proBNP
In the 60 patients with impaired EF <50 % the correlation
for the septal E/e’ (r = 0,361, r2 = 0,13, P = 0,005) and
average E/e’ (r = 0,377, r2 = 0,14, P = 0,01) was weaker.
For the lateral E/e’ the correlation was even not significant
(r = 0,234, r2 = 0,05, P = 0,13). In the 190 patients with EF
≥50 % the septal E/e’ (r = 0,426, r2 = 0,18, P <0,0001),
lateral E/e’ (r = 0,277, r2 = 0,07, P <0,01), and the average
E/e’ (r = 0,353, r2 = 0,12, P <0,0001) were all significantly
correlated to NT-proBNP.
Influence of other potential confounders on the correlations
between the diastolic parameters and NT-proBNP
A multivariable linear regression model was con-
structed to assess the potential influence of the clinical,
echocardiographic and biological factors on the correlation
between E/e’ ratio and NT-proBNP. On this model, thepotential confounders that were identified were: severe
COPD (standardized ß = −0,088, p = 0,05), obesity
(standardized ß = −0,092; p = 0,05), significant aortic
regurgitation (standardized ß = 0,096; p = 0,04), significant
mitral regurgitation (standardized ß = 0,148; p = 0,002),
altered ejection fraction (standardized ß = 0,314; p = 0,0001)
and renal dysfunction (standardized ß = 0,343; p = 0,0001).
Diabetes (p = 0,46), coronary artery disease (p = 0,56),
pulmonary hypertension (p = 0,14), previous CABG
(p = 0,09) did not significantly alter the correlation between
E/e’ and NT-proBNP.
After the exclusion of the 139 patients (56 %) with
more than mild aortic or mitral regurgitation, severe
renal dysfunction, obesity or severe COPD there
remained 111 patients (mean age 82 ± 8 years, 51 %
men), representing 44 % of the initial group. As seen in
Fig. 2, the septal E/e’ (r = 0,584, r2 = 0,34, P <0,0001), lat-
eral E/e’ (r = 0,377, r2 = 0,14, P <0,0001), and the average
E/e’ (r = 0,487, r2 = 0,24, P <0,0001) were now all signifi-
cantly better correlated to NT-proBNP.
In contrast, the level of linear correlation with the mitral
E/A ratio did not change (r = 0,255, r2 = 0,07, P = 0,01)
and the E-wave deceleration time was not at all correlated
to NT-proBNP (r = −0,065, r2 = 0,04, P = 0,5). As seen in
Fig. 3, the best-fit correlation lines were described by
quadratic equations, with r2 = 0,12, P = 0,002 for the E/A
ratio and non-significant results on all models for the
E-wave deceleration time.
The influence of the ejection fraction on the correlation
between the E/e’ ratio and NT-proBNP in the
confounder-free group
In the confounder-free group, the relations between
E/e’ and NT-proBNP were significant (r = 0,574, r2 = 0,33,
Fig. 1 Correlations between E/e’ ratio and Log10 NT-proBNP in the overall study population. a: septal point; b: lateral point; c: mean
septal-lateral E/e’
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for the lateral wall, and r = 0,484, r2 = 0,23, P <0,0001 for
the average value) in the 93 patients with preserved EF. In
the 18 patients with impaired EF all correlations were
non-significant: r = 0,258, r2 = 0,07, P = 0,3 for the septal
wall, r = −0,02, r2 = 0,00, P = 0,95 for the lateral wall,
and r = 0,058, r2 = 0,00, P = 0,8 for the average value.
Correlations between the diastolic parameters and
NT-proBNP in the obese patients
In the specific subgroup of 52 obese patients the septal
E/e’ (r = 0,260, r2 = 0,07, P = 0,07), lateral E/e’ (r = 0,150,
r2 = 0,02, P = 0,37), and the average E/e’ (r = 0,237,
r2 = 0,06, P = 0,15) were all not significantly correlated to
NT-proBNP. After exclusion of 10 patients with other
confounders, the septal E/e’ (r = 0,260, r2 = 0,07, P = 0,07),
lateral E/e’ (r = 0,256, r2 = 0,07, P = 0,17), and the average
E/e’ (r = 0,293, r2 = 0,09, P = 0,11) remained not signifi-
cantly correlated to NT-proBNP in the obese sugroup.Fig. 2 Correlations between E/e’ ratio and Log10 NT-proBNP in the patient
c: mean septal-lateral E/e’The value of the NT proBNP in obese patients was lower,
with a geometrical mean of 94 pmol/l, 95 % CI (81,142),
compared to 217 pmol/L in the non-obese patients
(P =0.027). In the other subgroups (COPD, renal dysfunc-
tion) a specific analysis was not possible because of the
limited number of patients.
Influence of previous coronary bypass surgery on septal
versus lateral E/e’ assessment
In the 53 patients (68 % men) with a history of cor-
onary artery bypass graft (CABG) surgery the septal E/e’
(r = 0,583, r2 = 0,34, P <0,0001), lateral E/e’ (r = 0,441,
r2 = 0,20, P <0,01), and the average E/e’ (r = 0,571, r2 =
0,33, P <0,0001) were also all significantly correlated to
NT-proBNP. After exclusion of 24 patients with the previ-
ously mentioned confounders these numbers were for
septal E/e’ (r = 0,577, r2 = 0,33, P <0,01), for lateral E/e’
(r = 0,507, r2 = 0,26, P <0,05), and for the average E/e’
(r = 0,565, r2 = 0,32, P <0,01).population without major confounders. a: septal point; b: lateral point;
Fig. 3 Correlation between E/A ratio and Log10 NT-proBNP. a: linear correlation; b: best-fit correlation line(quadratic equation). The regression
lines are displayed with blue lines, and the 95 % confidence intervals with black lines
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at the medial, lateral and average septal points
The level of correlation was significantly better for the
septal point when compared to the lateral (p < 0,0001).
There was also a difference favoring the septal point
against the average e’, but this difference did not reach a
significant p value (p = 0,051).
Discussion
In this study in elderly patients with severe symptomatic
AS the main findings were: 1) there is a significant cor-
relation between the E/e’ ratio and NT-proBNP, in
particular in patients without obesity, severe renal dys-
function, severe COPD, or significant left-sided valvular
regurgitation, 2) the correlation was best for the septal
E/e’ ratio, and 3) this latter correlation was preserved in
patients with a history of CABG.
In elderly patients with severe AS, clinical symptoms are
difficult to ascertain and less specific because of the normal
aging process and the multiple comorbidities usually
present in the AS patients referred for TAVI. In order to
help the decision for aortic valve intervention, an objective
parameter of increased LV filling pressure seems important
in their evaluation. The E/é ratio is the main stay of echo-
cardiography to indirectly assess LV filling pressure [21, 22].
The current guidelines recommend the use of the average
E/é ratio derived from the septal and lateral wall [22, 23].
However, evidence for the use of the average E/e’ ratio is
lacking and the specific accuracy of the septal or lateral E/e’is still debated. Each of the two E/e’ ratios has its specific
benefits. Translational movement of the heart may less
affect septal wall velocity and certainly Doppler beam angle
errors are less likely to occur when septal wall velocities are
measured. Also, it was shown that the septal E/e’ ratio best
correlated to LV filling pressures in subjects with preserved
systolic LV function [24] and in particular in the elderly [25].
On the other hand, Nagueh et al. claimed that “the lateral
E/e’ ratio was easier to quantify” [26, 27]. Obviously, a septal
or lateral localized myocardial wall infarction will negatively
influence the respective measurements. Therefore, patients
with such abnormalities were excluded from our study.
Our study population has some important unique fea-
tures. The patients were elderly with extensive aortic and
mitral annular calcifications and a significant number of
these patients had coronary artery disease and a history of
previous CABG. Despite these characteristics a good cor-
relation between the E/e’ ratio and NT-proBNP was
found. The best results were seen for the septal E/é ratio
with a correlation coefficient of 0.459. Exclusion for con-
founders (obesity, severe renal dysfunction, severe COPD, or
significant left-sided valvular regurgitation) resulted in even
better correlations. The best improvement was seen for
the septal E/é ratio with a correlation coefficient of 0.584.
The septal E/é ratio could be superior due to the afore-
mentioned reasons but also because of the extensive poster-
ior mitral annular calcification that may have resulted in
more problems in assessing the lateral annulus, which is a
part of the posterior annular ring [28].
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ence on septal function [29, 30] would affect the accuracy
of the septal E/é ratio. Surprisingly, a history of CABG
did not affect the correlation of the septal E/é ratio
with NT-proBNP.
Comparison to other studies and clinical implications
The level of correlation found between E/E’ and NT-
proBNP in our study in elderly patients with AS is quite
similar to correlations published in the literature in
general cardiac patients [31–33]. In AS little data are
available [16, 34]. There is only a very small study on
29 middle-aged (65 ± 12 years) severe AS patients [16]. In
that paper weak correlations were described between E/e’
and NT-proBNP with only significant results seen for the
septal E/e’. Because of the evidence in the literature
[16, 25], as well as the results of the present study
and the specific practical benefits, the use of septal E/e’
ratio rather than the lateral or average E/e’ should be
encouraged, until other sound data are available from
prospective large-scale trials such as the EURO-FILLING
study [35].
In the global population included here, the correlation
between the surrogate markers of LV filling pressures
remains moderate. Only about 44 % of the symptomatic
elderly patients with severe aortic stenosis displayed
strong correlations. From a practical clinical standpoint,
care should be taken in interpreting the results of the
usual diastolic function parameters in the presence of
the confounders defined in this study: more than mild
aortic/mitral regurgitation, severe renal impairement,
severe COPD, obesity and left ventricular dysfunction.
Apart from the negative impact of impaired EF on the
correlation between E/e’ and NT-proBNP, the influence
of obesity was striking. Even for the septal E/e’ ratio no
significant correlation was seen, probably because of the
well-known paradoxically lower NT-proBNP levels than
in normal weight patients for the same filling pressures
[36]. In such patients we can only speculate that the E/e’
ration better reflects LV filling pressures.
These findings could have an impact on the costs of
medical care, since adding a NT proBNP assay to the
routine evaluation is relatively expensive [37] and not
covered by medical insurances, while E/e’ ratio can be
measured repetitively during each echocardiographic
examination, without any supplemental risk or cost for
the patient.
Study limitations
As mentioned above, the population included in this
study was carefully selected by a “heart team” according
to present guidelines on the management of valvular
heart disease [20]. That means first of all that they had
to have clinical symptoms in association with a severeaortic stenosis in order to be considered for TAVI. An
asymptomatic control group with severe aortic stenosis
could have better demonstrated the role of echocardio-
graphic data in the decision making. Such a group is
difficult to constitute in an elderly population with several
comorbidities.
The cross-sectional nature of the study could be a
limitation in itself. However, data collection in this
population was very rigorous, according to a very strict
and prospectively designed protocol.
Although it demonstrates a correlation between echo-
cardiographic and biological markers of elevated left
ventricular filling pressures, it is possible that the cutoff
value of 15 for the septal E/e’ is too sensitive (practically
all the patients having an E/E’ ratio above this value,
with a mean of 20 ± 9), or that all the selected patients
had chronically elevated LVEDP, as reflected by the
mean value of NT proBNP = 217pmol/l. Unfortunately, a
better cutoff point could not be determined from our
data, because the LVEDP was measured in all patients
during the initial phase of the intervention, before TAVI,
but already on general anesthesia, which invariably leads
to dramatic changes in pressures.
Conclusion
In elderly patients with severe symptomatic AS there
is a significant correlation between the E/e’ ratio and
NT-proBNP, in particular after exclusion of confounders.
The correlation was best for the septal E/e’ ratio and was
preserved in patients with a history of CABG.
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